연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
2895. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
Javier Cortes 1, Hope S Rugo 1, David W Cescon 1, Seock-Ah Im 1, Mastura M Yusof 1, Carlos Gallardo 1, Oleg Lipatov 1, Carlos H Barrios 1, Jose Perez-Garcia 1, Hiroji Iwata 1, Norikazu Masuda 1, Marco Torregroza Otero 1, Erhan Gokmen 1, Sherene Loi 1, Zifang Guo 1, Xuan Zhou 1, Vassiliki Karantza 1, Wilbur Pan 1, Peter Schmid 1; KEYNOTE-355 Investigators
N Engl J Med. 2022 Jul 21;387(3):217-226.
Link
2894. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi 1, William Jacot 1, Toshinari Yamashita 1, Joohyuk Sohn 1, Maria Vidal 1, Eriko Tokunaga 1, Junji Tsurutani 1, Naoto T Ueno 1, Aleix Prat 1, Yee Soo Chae 1, Keun Seok Lee 1, Naoki Niikura 1, Yeon Hee Park 1, Binghe Xu 1, Xiaojia Wang 1, Miguel Gil-Gil 1, Wei Li 1, Jean-Yves Pierga 1, Seock-Ah Im 1, Halle C F Moore 1, Hope S Rugo 1, Rinat Yerushalmi 1, Flora Zagouri 1, Andrea Gombos 1, Sung-Bae Kim 1, Qiang Liu 1, Ting Luo 1, Cristina Saura 1, Peter Schmid 1, Tao Sun 1, Dhiraj Gambhire
N Engl J Med. 2022 Jul 7;387(1):9-20.
Link
2893. Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
Massimo Cristofanilli 1, Hope S Rugo 2, Seock-Ah Im 3, Dennis J Slamon 4, Nadia Harbeck 5, Igor Bondarenko 6, Norikazu Masuda 7, Marco Colleoni 8, Angela DeMichele 9, Sherene Loi 10, Hiroji Iwata 11, Ben O'Leary 12, Fabrice André 13, Sibylle Loibl 14, Eustratios Bananis 15, Yuan Liu 16, Xin Huang 16, Sindy Kim 16, Maria Jose Lechuga Frean 16, Nicholas C Turner 12
Clin Cancer Res. 2022 Aug 15;28(16):3433-3442
Link
2892. Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2- Advanced Breast Cancer in the MONALEESA-3 Trial
Guy Jerusalem 1, Thomas E Delea 2, Migule Martin 3, Michelino De Laurentiis 4, Arnd Nusch 5, J Thaddeus Beck 6, Arlene Chan 7, Seock-Ah Im 8, Patrick Neven 9, Alexander Lonshteyn 2, David Chandiwana 10, Brad Lanoue 10, Peter A Fasching 11
Clin Breast Cancer. 2022 Jun;22(4):326-335.
Link
2891. The longitudinal effects of chronotype on chemotherapy-induced nausea and vomiting in patients with breast cancer receiving neoadjuvant chemotherapy
Sanghyup Jung 1, Kyung-Lak Son 2, Saim Jung 1, Jung Yoon Moon 1, Gyu Han Oh 3, Chan-Woo Yeom 4, Kwang-Min Lee 5, Won-Hyoung Kim 6, Dooyoung Jung 7, Tae-Yong Kim 8, Seock-Ah Im 9, Kyung-Hun Lee 8, David Spiegel 10, Bong-Jin Hahm 11
J Psychosom Res. 2022 Jun;157:110804.
Link
2890. Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
Javier Cortés 1, Sung-Bae Kim 1, Wei-Pang Chung 1, Seock-Ah Im 1, Yeon Hee Park 1, Roberto Hegg 1, Min Hwan Kim 1, Ling-Ming Tseng 1, Vanessa Petry 1, Chi-Feng Chung 1, Hiroji Iwata 1, Erika Hamilton 1, Giuseppe Curigliano 1, Binghe Xu 1, Chiun-Sheng Huang 1, Jee Hyun Kim 1, Joanne W Y Chiu 1, Jose Luiz Pedrini 1, Caleb Lee 1, Yali Liu 1, Jillian Cathcart 1, Emarjola Bako 1, Sunil Verma 1, Sara A Hurvitz 1; DESTINY-Breast03 Trial Investigators
N Engl J Med. 2022 Mar 24;386(12):1143-1154.
Link
2889. Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer
Kyung-Lak Son 1, Dooyoung Jung 2, Kwang-Min Lee 3, Chan-Woo Yeom 4, Gyu Han Oh 5, Tae-Yong Kim 6 7, Seock-Ah Im 6 7 8, Kyung-Hun Lee 6 7, David Spiegel 9, Bong-Jin Hahm 10
J Korean Med Sci. 2022 Feb 7;37(5):e34.
Link
2888. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Peter Schmid 1, Javier Cortes 1, Rebecca Dent 1, Lajos Pusztai 1, Heather McArthur 1, Sherko Kümmel 1, Jonas Bergh 1, Carsten Denkert 1, Yeon Hee Park 1, Rina Hui 1, Nadia Harbeck 1, Masato Takahashi 1, Michael Untch 1, Peter A Fasching 1, Fatima Cardoso 1, Jay Andersen 1, Debra Patt 1, Michael Danso 1, Marta Ferreira 1, Marie-Ange Mouret-Reynier 1, Seock-Ah Im 1, Jin-Hee Ahn 1, Maria Gion 1, Sally Baron-Hay 1, Jean-François Boileau 1, Yu Ding 1, Konstantinos Tryfonidis 1, Gursel Aktan 1, Vassil
N Engl J Med. 2022 Feb 10;386(6):556-567.
Link
2887. Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study
Ian E Krop 1, Seock-Ah Im 2, Carlos Barrios 3, Hervé Bonnefoi 4, Julie Gralow 5, Masakazu Toi 6, Paul A Ellis 7, Luca Gianni 8, Sandra M Swain 9, Young-Hyuck Im 10, Michelino De Laurentiis 11, Zbigniew Nowecki 12, Chiun-Sheng Huang 13, Louis Fehrenbacher 14, Yoshinori Ito 15, Jigna Shah 16, Thomas Boulet 17, Haiying Liu 16, Harrison Macharia 17, Peter Trask 16, Chunyan Song 16, Eric P Winer 1, Nadia Harbeck 18
Affiliations expand
J Clin Oncol. 2022 Feb 10;40(5):438-448.
Link
2886. Accuracy of preoperative clinical staging for locally advanced gastric cancer in KLASS-02 randomized clinical trial
Kim DJ, Hyung WJ, Park YK, Lee HJ, An JY, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Yang HK, Han SU, Kim W
Front Surg. 2022 Sep 23;9:1001245.
Link